FDA: We’re working to reduce the risks

The FDA’s first priority is patient safety.

The FDA has been working for several years to reduce the risk of patient infections associated with reusable endoscopes — small, flexible lighted tubes that allow doctors to see inside patients and treat certain medical conditions in a less invasive manner than traditional surgery. The devices, which include duodenoscopes, are reprocessed, or cleaned and disinfected, for use between patients.

How Automated Compounding Can Reduce Hospital Costs

The $200 million fund created to compensate victims of the 2012 meningitis outbreak tied to tainted drugs from the New England Compounding Center is an extreme example of how expensive compounding errors can be.

Tricare: Compounded medication orders fall sharply

A change to Tricare’s compounded medication coverage policy May 1 slashed costs for these medications by more than 74 percent in less than a month.

But for some patients, the switch has been anything but easy.